CD4 and melanoma: Primary human B cells activated in vitro with CD40 ligand and subsequently pulsed with melanoma tumor antigens, efficiently processed and presented MHC class II-restricted peptides to specific CD4+ T cell clones, generating melanoma-specific T cells.106